Czech EMMA Group acquires Romanian Diamedex
18 March 2025
26 March 2025
TCF Capital acquires 42.5% stake in Pilulka Lékárny.
TCF Capital of Tomáš Čupr, founder of Rohlik, has exercised its option to buy a 42.5% stake in Pilulka Lékárny. The option was part of a CZK 80m loan TCF Capital granted to Pilulka last year.
Pilulka operates an e-shop and a network of pharmacies. In recent years, the company ran into problems, ended its foreign expansion and started reorganization and transformation. Its market capitalization on the Prague Stock Exchange has shrunk to a tenth over the past three years.
TCF Capital manages assets worth over EUR 720 million. Apart from its core asset Rohlik Group, it mainly focuses on e-commerce companies and technology start-ups. The transaction is subject to the approval of the CNB regulator.